Insider Cluster (2 insiders) ·Filed Sep 11, 2026

PHVS

Pharvaris N.V.
NEUTRAL
Impact 3/10
Horizondays Processed21d 2h ago
Insider cluster: 2 insiders, $911K total
Actionable Insight • Neutral

The insider sales are small and likely liquidity-driven after option exercises. Monitor for any material news (pipeline updates, regulatory filings) that could explain the timing, but no immediate trading action is warranted.

DirectionNeutral
Confidencehigh
Horizondays
Latest settled — T+5d
PHVS ▼ -4.34% at T+5d
NEUTRAL call ✗ call lost -4.34% · α vs SPY -4.12% · entry $38.02 → $36.37
Next anchor: T+20d in 7d
Latest observation: T+11 -23.44% FF3 residual α
Entry anchored
Sep 11, 12:25 PM ET
via 1-min bar
T+1d
+2.21%
call +2.21% · α +2.66%
$38.86
settled 18d ago
T+5d
-4.34%
call -4.34% · α -4.12%
$36.37
settled 14d ago
T+20d
—
call — · α —
—
in 7d
T+60d
—
call — · α —
—
in 2mo

Price Chart

Loading chart...

Executive Summary

Two Pharvaris insiders, including President Lu Peng, sold a combined $911K in open-market sales this week. The sales follow derivative exercises and are modest relative to the $2.6B market cap (~0.04%), making them routine in scale. No bearish signal is warranted given the small proportionality and the company's strong analyst consensus (90% bullish).

Key Financial Metrics

Direction
selling
Total Value
$911.0K
Insiders
2

Key Facts

  • President Lu Peng sold 15,000 shares at $40.68 for $610K on 2026-09-08
  • Director Robert Glassman sold 8,000 shares at $37.55 for $300K on 2026-09-09
  • Both sales followed derivative exercises (non-cash events) — Lu exercised options at $2.59, Glassman exercised at $20 and $0
  • Total open-market sales of $911K represent ~0.04% of PHVS's $2.6B market cap
  • No open-market purchases were made by any insider in the cluster

Financial Impact

Total insider sales of $911K, or ~0.04% of market cap — trivial relative to company size

dilution

Risk Factors

  • Insider sales, while small, could precede negative news if they accelerate in size or involve C-suite executives selling larger positions
  • Biotech stock volatility around clinical data readouts could amplify any future insider activity

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
90% bullish (21 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-PHVS-1789143949683
37 reports for PHVS
Performance horizon
90% Hit rate 9 of 10 directional calls best @ T+60▲ +21.31%Mar 20, 2026
Filters
Rows
Reports for PHVS — sortable, filterable
TypeNow
Sep 15, 2026
17d ago
Insider Cluster
BEARISH ★ 5/10
$38.06 $36.37▲ +4.44%▲ +5.26%$31.07 (+18.38%)
Sep 14, 2026
17d ago
144
NEUTRAL ★ 2/10
$38.06 $35.20▼ −7.51%▼ −9.63%$31.07 (−18.38%)
Sep 14, 2026
18d ago
Insider Cluster
NEUTRAL ★ 3/10
$38.86 $36.02▼ −7.31%▼ −7.41%$31.07 (−20.06%)
Sep 11, 2026
21d ago
Insider Cluster
NEUTRAL ★ 3/10
$38.02 $36.37▼ −4.34%▼ −4.12%$31.07 (−18.29%)
Sep 8, 2026
24d ago
6-K
BULLISH ★ 8/10
$37.84 $38.86▲ +2.70%▲ +3.36%$31.07 (−17.90%)
Aug 12, 2026
7w ago
6-K
NEUTRAL ★ 6/10
$36.46 $36.27▼ −0.52%▼ −0.08%$31.07 (−14.80%)
Aug 12, 2026
7w ago
Press Release
BULLISH ★ 7/10
$36.46 $36.27▼ −0.52%▼ −0.08%$31.07 (−14.80%)
Aug 6, 2026
8w ago
Press Release
NEUTRAL ★ 4/10
$34.45 $34.04▼ −1.19%▼ −2.40%$31.07 (−9.83%)
Jul 6, 2026
12w ago
Press Release
BULLISH ★ 6/10
$33.22 $35.07▲ +5.57%▲ +5.08%$31.07 (−6.49%)
Jul 1, 2026
13w ago
Insider Cluster
NEUTRAL ★ 3/10
$33.86 $35.96▲ +6.20%▲ +5.27%$31.07 (−8.25%)
Showing 10 of 37

US Market Status

Market Open — Closes in 53m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Sep 11, 2026